Evolv Technologies Q2 2024 Adj. EPS $(0.06) Beats $(0.07) Estimate, Sales $25.500M Beat $23.842M Estimate
Portfolio Pulse from Benzinga Newsdesk
Evolv Technologies (NASDAQ:EVLV) reported Q2 2024 adjusted EPS of $(0.06), beating the estimate of $(0.07). Sales were $25.5M, surpassing the $23.842M estimate and showing a 28.63% increase from the same period last year.
August 08, 2024 | 8:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evolv Technologies reported better-than-expected Q2 2024 results with an adjusted EPS of $(0.06) beating the $(0.07) estimate and sales of $25.5M surpassing the $23.842M estimate. This represents a 28.63% increase in sales from the same period last year.
The better-than-expected EPS and sales figures, along with a significant year-over-year increase in sales, are likely to positively impact EVLV's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100